How was the vaccine tested? How effective is the vaccine? How, when and where is the vaccine given? Are there any side effects? Who should and should not have the vaccine? How much does it cost? Why was the HPV vaccine program introduced? Has the program been successful? Budget Proposal. Stories of Cancer Research. Driving Discovery. Highlighted Scientific Opportunities. Research Grants. Research Funding Opportunities.
Cancer Grand Challenges. Research Program Contacts. Funding Strategy. Grants Policies and Process. Introduction to Grants Process. NCI Grant Policies. Legal Requirements. Step 3: Peer Review and Funding Outcomes. Manage Your Award.
Grants Management Contacts. Prior Approvals. Annual Reporting and Auditing. Transfer of a Grant. Grant Closeout.
Cancer Training at NCI. Resources for Trainees. Funding for Cancer Training. Building a Diverse Workforce. National Cancer Act 50th Anniversary Commemoration. Resources for News Media.
Media Contacts. Cancer Reporting Fellowships. Advisory Board Meetings. Social Media Events. Cancer Currents Blog. Contributing to Cancer Research. Strategic Planning. Principal Deputy Director's Page. Previous NCI Directors. NCI Frederick. Advisory Boards and Review Groups. NCI Congressional Justification. Current Congress. Committees of Interest. Legislative Resources.
Recent Public Laws. Search Search. Cancer-Causing Substances. Chronic Inflammation. Common Cancer Myths and Misconceptions. Infectious Agents.
Who should get HPV vaccination? How many doses of HPV vaccine are needed? How effective are HPV vaccines? How do HPV vaccines work? Why is HPV vaccination important? Are HPV vaccines safe? Do women who have been vaccinated against HPV still need to be screened for cervical cancer? How much does HPV vaccination cost, and will insurance pay for it? What research is being done on strategies to prevent HPV infection? What are HPV vaccines?
HPV vaccination is routinely recommended at age 11 or 12 years; vaccination can be started at age 9 years. HPV vaccination is recommended for all persons through age 26 years who were not adequately vaccinated earlier. Adults ages 27 through 45 years. Instead, ACIP recommends that clinicians consider discussing with their patients in this age group who were not adequately vaccinated earlier whether HPV vaccination is right for them.
HPV vaccination in this age range provides less benefit because more people have already been exposed to the virus. Persons who are pregnant. HPV vaccination should be delayed until after pregnancy, but pregnancy testing is not required before vaccination. There is no evidence that vaccination will affect a pregnancy or harm a fetus. GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by human papillomavirus HPV Types 16, 18, 31, 33, 45, 52, and 58; cervical, vulvar, vaginal, and anal precancerous or dysplastic lesions caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58; and genital warts caused by HPV Types 6 and The oropharyngeal and head and neck cancer indication is approved under accelerated approval based on effectiveness in preventing HPV-related anogenital disease.
Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. GARDASIL 9 does not eliminate the necessity for vaccine recipients to undergo screening for cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers as recommended by a health care provider.
Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following HPV vaccination. When syncope is associated with tonic-clonic movements, the activity is usually transient and typically responds to restoring cerebral perfusion.
The Patient Information also is available. Merck does not review or control the content at the site to which this link connects. Merck makes no representation with respect to the content of any non-Merck site. Skip to content. For Adolescents. For Adults. Human papillomavirus. Epidemiology and Prevention of Vaccine-Preventable Diseases. HPV and oropharyngeal cancer.
0コメント